Published price vs quote-only
altRx vs Shed: Which One Publishes Its Price? (2026)
altRx or Shed? Side-by-side 2026 pricing, medication and service comparison, extended to six and twelve-month totals.
Published · Pricing as published in our provider dataset, synced · Editorial scores 9.9 and 9.2 out of 10
We may receive compensation when you click partner links. Rankings are based on research methodology, not sponsorship.
If altRx and Shed are the two tabs still open, the deciding information is not on either homepage — it is in what happens after the first month.
altRx publishes what it charges — Semaglutide $89/mo, tirzepatide $149/mo. Shed does not: Shed does not publish standard pricing; you receive a personalized quote after completing the intake assessment. That asymmetry is the comparison, because you can only price-check one of these two before handing over a medical history.
The comparison below starts from published pricing, converts it into annual cost, and then asks what the more expensive side is delivering for the difference. Undisclosed pricing is treated as a finding, not rounded into an estimate.
The short answer
- Easier to price in advance
- altRx — Semaglutide $89/mo, tirzepatide $149/mo. The other side quotes after intake, so a like-for-like total is not available before you apply.
- FDA-approved medication
- Shed — The only side that can write an approved brand-name product at all — it offers name-brand FDA-approved GLP-1 and compounded GLP-1.
- Tirzepatide access
- altRx — Tirzepatide at $149/mo; the other side publishes semaglutide only.
- Easiest to pay for
- altRx — Affirm, Klarna and Afterpay.
Side-by-side comparison
The rows below are the ones that differ enough between these two to be worth your attention.
| altRx | Shed | |
|---|---|---|
| Advertised price | Semaglutide $89/mo, tirzepatide $149/mo | 10% off the first month, price quoted after intake |
| Rate after promotions | $89/mo | not published before intake |
| Pricing structure | Flat rate at every dose | Quoted only after intake |
| Medication | Compounded semaglutide and compounded tirzepatide | Name-brand FDA-approved GLP-1 and compounded GLP-1 |
| Price transparency | Published upfront | Quote only, after intake |
| State coverage | Not available in every state | Not published |
| Tirzepatide | $149/mo | Not published |
| Support model | Clinician messaging included | Coaching built into the plan |
| Shipping | Free, discreet 2-day delivery | Home delivery after clinician review |
| Patient reviews | 14,820 | 8,500 |
| eRxDoctor score | 9.9/10 | 9.2/10 |
What altRx and Shed actually cost over a year
Comparing entry prices across these two would be actively misleading, because they escalate differently. Below, both are carried out to six and twelve months so the comparison holds at the point it matters.
| altRx | Shed | |
|---|---|---|
| First month | $89 | Not published |
| Months 2 onward | $89/mo | Not published |
| 6-month total | $534 | Not computable |
| 12-month total | $1,068 | Not computable |
| Best published plan | No multi-month discount published | No multi-month discount published |
A like-for-like annual total is not available for Shed: Shed does not publish standard pricing; you receive a personalized quote after completing the intake assessment. Treat any comparison that quotes one as an estimate someone else has made for you.
Pricing you can check, and pricing you cannot
With altRx the arithmetic is available in advance — Semaglutide $89/mo, tirzepatide $149/mo, on flat rate at every dose terms — so it can be compared against anything else on the market.
Shed runs the other way around — Shed does not publish standard pricing; you receive a personalized quote after completing the intake assessment. There are defensible reasons for that; personalized plans genuinely do vary. The practical effect is still that you cannot comparison-shop it, and a completed intake is exactly the moment a quote lands with the most leverage.
Treat Shed's quote as the start of the comparison rather than the end of it, and check specifically what happens to the number at higher doses.
How altRx works
altRx is the most affordable GLP-1 program, limited offer: semaglutide $89/month and tirzepatide $149/month. 100% online medical visits, no membership, insurance or hidden fees, free and discreet 2-day delivery. What it is really selling here is the cheapest published tirzepatide rate on this list at $149, with the injection kit included.
Getting started means 100% online medical visits, after which free, discreet 2-day delivery. Pricing runs on a flat rate at every dose basis, published upfront.
Ongoing care is responsive care team for ongoing clinician-guided support, and the medication list runs to compounded semaglutide and compounded tirzepatide.
altRx pros
- No commitment, cancel anytime
- Free and discreet 2-day delivery
- Responsive care team for ongoing clinician-guided support
- Complete treatment kit: vials, syringes, prep pads, and step-by-step guidance
altRx cons
- Not available in all U.S. states
- Compounded medication, not FDA-approved branded product
Against Shed specifically, the trade you are making: the rate is a limited offer and the platform does not operate in every state.
Shed in detail
Shed offers both name-brand and compounded GLP-1 weight loss medications with integrated coaching, a 2-minute approval assessment, and 10% off your first month. In this pairing, its distinguishing feature is one of the few platforms that will write either a name-brand or a compounded GLP-1, with coaching bundled into the plan rather than sold beside it.
Intake is 2-minute approval assessment. Fulfillment is home delivery after clinician review. The commercial terms are quoted only after intake, quote only, after intake.
Support: continuous coaching built into every treatment plan. The medications on offer are name-brand FDA-approved GLP-1 and compounded GLP-1.
Shed pros
- Continuous coaching is integrated into treatment, not just a prescription
- Offers both FDA-approved name-brand GLP-1 and compounded options on one platform
- 10% off your first month for new patients
- Fast 2-minute approval assessment
Shed cons
- Standard pricing is not published, you receive a personalized quote after intake
- Coaching-bundled model can cost more than bare-prescription platforms
- Name-brand options carry significantly higher costs than compounded alternatives
The cost of choosing this over altRx: you cannot know what you will pay until you have finished the intake.
Picking between them
Choose altRx if:
- you want the full price in front of you before completing an intake
- you need to spread the cost — Affirm, Klarna and Afterpay
- you want tirzepatide available without changing provider later
- you want the price you sign up at to survive titration
Choose Shed if:
- you want an FDA-approved finished medication rather than a compounded preparation
- you want continuous coaching built into every treatment plan rather than a prescription alone
- you would get real value from one of the few platforms that will write either a name-brand or a compounded GLP-1, with coaching bundled into the plan rather than sold beside it
- the level of clinical contact suits you: continuous coaching built into every treatment plan
Honest trade-offs
On price. Only altRx publishes a rate you can plan against (Semaglutide $89/mo, tirzepatide $149/mo). The other quotes after intake, which is a cost of a different kind: you cannot budget the year in advance.
On commitment. Neither publishes a multi-month discount, so both are month-to-month decisions and neither asks you to prepay for a response you have not had yet. Financing is available through altRx (Affirm, Klarna and Afterpay).
On clinical contact. altRx provides responsive care team for ongoing clinician-guided support. Shed provides continuous coaching built into every treatment plan. Both are asynchronous-first services and neither replaces a physician who can examine you.
On medication. altRx covers compounded semaglutide and compounded tirzepatide; Shed covers name-brand FDA-approved GLP-1 and compounded GLP-1. Only altRx publishes a tirzepatide route, which matters if semaglutide underdelivers.
The medication, not the platform
Neither altRx nor Shed manufactures the molecule it prescribes, and the clinical evidence behind GLP-1 treatment belongs to the drug rather than to any platform selling access to it.
The NIH position is that weight-management medication works alongside changes in eating and activity, not instead of them, per NIH, NIDDK.
Cardiovascular benefit has been demonstrated for semaglutide in a specific population: adults with overweight or obesity and existing cardiovascular disease but no diabetes, per NEJM, SELECT.
Read alongside the pricing above, that is the case for treating the medication decision as clinical and the provider decision as commercial. They are not the same choice.
altRx vs Shed: common questions
What happens when altRx's promotional price ends?
The rate moves to $89/mo, a 0% increase on the advertised entry price. Budget from that number rather than the headline, because it is the one you will pay for eleven of your first twelve months.
Which is cheaper to start, altRx or Shed?
Only altRx publishes a first-month figure (Semaglutide $89/mo, tirzepatide $149/mo). The other quotes after intake, so a starting-cost comparison is not available in advance.
How much does Shed cost?
Shed does not publish standard pricing; you receive a personalized quote after completing the intake assessment. That is the honest answer, and it is the main practical drawback next to altRx, which publishes Semaglutide $89/mo, tirzepatide $149/mo upfront. If you go through the intake, ask for the month-two and maintenance-dose prices in writing before paying for the first month.
Which has more patient reviews, altRx or Shed?
altRx, with 14,820 against 8,500. Ratings across this market cluster tightly, so volume is the more useful signal: it indicates how much operational load the platform has already absorbed, not how good the medication is.
Is coaching included with altRx or Shed?
Shed includes continuous coaching built into every treatment plan in the monthly price. altRx provides responsive care team for ongoing clinician-guided support, without a separate coaching program. If medication alone has failed you before, the bundled version is the one to price properly rather than the one to cut.
What happens if I stop taking the medication?
Weight regain is the documented pattern, and it is not specific to either platform. Trial extension data has recorded participants regaining most of the weight they lost within a year of stopping semaglutide. Both altRx and Shed price on a monthly basis, so treat the twelve-month figure as the realistic commitment rather than a first-month experiment.
The verdict
Neither of these two publishes enough for a clean cost verdict, which is itself the finding. altRx leads on the cheapest published tirzepatide rate on this list at $149, with the injection kit included; Shed leads on one of the few platforms that will write either a name-brand or a compounded GLP-1, with coaching bundled into the plan rather than sold beside it.
Before choosing either, get the maintenance-dose price in writing. Without it, any comparison — including this one — is working with half the information.
Whichever way you go, the medication is the same class of drug and the clinical questions belong to a clinician. What you are choosing here is a billing model and a support structure.
Keep comparing
- altRx vs Start WillowBudget vs premium
- altRx vs MedViBudget vs premium
- Shed vs MedViPublished price vs quote-only
- Shed vs Start WillowPublished price vs quote-only
See every provider in context on the weight loss rankings, or browse the full comparison index.
Disclaimers and methodology
Medical content is informational only and does not replace professional diagnosis, treatment, or emergency care.
Some links are affiliate links and may generate commission at no extra cost to you.
Pricing reflects what each provider published as of the sync date above and changes frequently; confirm the current rate, and the rate at your maintenance dose, before you pay. Six- and twelve-month totals are calculated from those published rates and exclude anything a provider bills separately.
eRxDoctor is an independent publisher. It is not a medical provider, is not affiliated with or endorsed by altRx or Shed, and does not sell treatment. Read our ranking methodology.